Randi Hatton
Family · Tuscaloosa, ALNPI 1578153391
Payments from drug & device makers
Across 117 payments — averaging $17.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$408
- Lilly USA, LLC$208
- Pfizer$166
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$154
- Novo Nordisk$125
- Corium, LLC$94
- plus $840 from 23 others
What the payments were for
- Speaking & faculty fees$231%
- Food & beverage$1,97299%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 27 | $408 |
| Lilly USA, LLC | 13 | $208 |
| Pfizer | 14 | $166 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $154 |
| Novo Nordisk | 8 | $125 |
| Corium, LLC | 5 | $94 |
| Otsuka America Pharmaceutical, Inc. | 5 | $80 |
| Astellas Pharma US Inc | 4 | $73 |
| Sumitomo Pharma America, Inc. | 4 | $62 |
| Exact Sciences | 4 | $61 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $55 |
| Amgen | 3 | $49 |
| Boehringer Ingelheim | 3 | $49 |
| Tris Pharma Inc | 2 | $43 |
| IBSA Pharma Inc. | 2 | $41 |
| Ardelyx, Inc. | 2 | $38 |
| BD | 1 | $36 |
| Axsome Therapeutics, Inc. | 2 | $34 |
| AstraZeneca | 2 | $32 |
| Exeltis, USA Inc. | 1 | $24 |
| Medicure Pharma Inc. | 1 | $23 |
| Dexcom, Inc. | 1 | $19 |
| Tolmar, Inc. | 1 | $18 |
| Sage Therapeutics, LLC | 1 | $18 |
| Supernus Pharmaceuticals, Inc. | 1 | $18 |
| Bayer | 1 | $18 |
| Antares Pharma, Inc. | 1 | $17 |
| Shield Therapeutics Inc | 1 | $17 |
| Organon | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRULANCE$125
How this compares
$1,995 in reported general payments places this provider in the 75th percentile of 3,415 family providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 12 | $17,230 |
| GemtesaVibegron | 14 | $7,744 |
| Telmisartan | 34 | $1,213 |
| Estradiol | 21 | $1,181 |
| Rosuvastatin Calcium | 88 | $1,177 |
| SynthroidLevothyroxine Sodium | 11 | $906 |
| Levothyroxine Sodium | 56 | $644 |
| Bupropion XlBupropion Hcl | 14 | $492 |
| Losartan Potassium | 32 | $444 |
| Omeprazole | 41 | $416 |
| Montelukast Sodium | 25 | $396 |
| Lisinopril | 27 | $386 |
| Pantoprazole Sodium | 13 | $342 |
| Famotidine | 27 | $320 |
| Atorvastatin Calcium | 20 | $305 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $49 | $17,23012 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $62 | $7,74414 claims |
| AbbVieSynthroid | $408 | $90611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,415 family providers in Alabama.
Other family in Tuscaloosa
- Justin SimpsonTuscaloosa$43K
- Ashley StinesTuscaloosa$29K
- Lauren KyzarTuscaloosa$17K
- Dee GuyTuscaloosa$14K
- Haley TippsTuscaloosa$14K
- Jeremy KelleyTuscaloosa$13K
- Justin WilsonCullman$1.1M
- Leigh Ann ChildressHuntsville$240K
- Molly ReevesAuburn$158K
- Christina CanteyHuntsville$118K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.